DiaSorin S.p.A. (OTCMKTS:DSRLF - Get Free Report) was the target of a large increase in short interest in May. As of May 15th, there was short interest totalling 146,400 shares, an increase of 32.6% from the April 30th total of 110,400 shares. Based on an average trading volume of 100 shares, the days-to-cover ratio is currently 1,464.0 days. Currently, 0.3% of the company's stock are short sold.
DiaSorin Stock Performance
DiaSorin stock remained flat at $104.69 during mid-day trading on Friday. The business's 50 day moving average is $107.29 and its 200-day moving average is $106.71. DiaSorin has a 1 year low of $100.01 and a 1 year high of $109.60.
DiaSorin Company Profile
(
Get Free Report)
DiaSorin S.p.A. engages in development, manufacture, and distribution of immunodiagnostics and molecular diagnostics testing kits in Europe, Africa, North America, Central and South America, the Asia Pacific, and China. The company provides various immunodiagnostic LIAISON platforms, including LIAISON XS, LIASON IQ, LIAISON XL, LIAISON XXL, and LIAISON XL LAS.
Featured Articles
Before you consider DiaSorin, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and DiaSorin wasn't on the list.
While DiaSorin currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
If a company's CEO, COO, and CFO were all selling shares of their stock, would you want to know? MarketBeat just compiled its list of the twelve stocks that corporate insiders are abandoning. Complete the form below to see which companies made the list.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
